Only Medtronic delivers a truly integrated diabetes management system
The components of the Paradigm® Veo™ System work in sync with each other.
Each component forms part of a therapy which improves clinical results. 1,2,3,4
Integrated system
Overview of components
MiniLink™ Transmitter and Continuous Glucose Sensor – Wireless, integrated communication
  • Combined with the sensor, Veo allows you to view your glucose values for up to 6 days at a time
  • New calibration algorithm in the Veo improves accuracy and sensitivity in hypoglycaemia detection
  • Sensor measures glucose levels in interstitial fluid
  • Small, discreet and waterproof to a depth of 2.4m
Bayer's CONTOUR® LINK blood glucose meter – Wireless transmission, accurate information
  • Minimises data entry mistakes through wireless transmission of blood glucose results to the pump
  • Simplifies bolus dosing with Bolus Wizard® calculator and reduces steps required for sensor calibration
  • No coding necessary - No Coding™ technology eliminates miscoding errors
CareLink™ Therapy Management Software – Reports for better understanding and control
  • Superior insight into your glycaemic control thanks to pump, CGM and BG meter data
  • Secure data uploading at home via CareLink™ Personal allowing you to view your own reports
References:
  1. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774.
  2. Bruttomesso D. et al., Continuous subcutaneous insulin infusion (CSII) in Veneto region: efficacy, acceptability and quality of life. Diabet Med., 2002,19: 628-634.
  3. Garg S, Zisser H, Schwartz S. et. al., Improvements in glycaemic excursions with a transcutaneous, real-time continuous glucose sensor. Diabetes Care. 2006. 29:44-50.
  4. Corriveau, et al. Effect of CareLink, an internet-based insulin pump monitoring system, on glycemic control in children in type 1 diabetes mellitus. Journal of Pediatric Diabetes.2008;9 (Part II):16-22.